Sanmarti, R., Veale, D. J., Martin-Mola, E., Escudero-Contreras, A., González, C., Ercole, L., Alonso, R., Fonseca, J. E., Alcañiz, C., Álvaro-Gracia, J. M., Balsa, A., de Pablos, J. L., Miguel, C. D., Rodríguez, J. M., Alves, J., Aurrecoechea, E., Calvo, J., Belzunegui, J., Blanco, F., et al. (2019). Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial. Arthritis and Rheumatology, 71(10), 1616-1625. https://doi.org/10.1002/ART.40905